vs
Side-by-side financial comparison of SMARTFINANCIAL INC. (SMBK) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $53.8M, roughly 1.7× SMARTFINANCIAL INC.). SMARTFINANCIAL INC. runs the higher net margin — 25.4% vs 25.0%, a 0.4% gap on every dollar of revenue. Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 15.4%).
SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
SMBK vs VCEL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $53.8M | $92.9M |
| Net Profit | $13.7M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | — | 24.1% |
| Net Margin | 25.4% | 25.0% |
| Revenue YoY | — | 23.3% |
| Net Profit YoY | 21.6% | 17.3% |
| EPS (diluted) | $0.81 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $53.8M | — | ||
| Q4 25 | $53.3M | $92.9M | ||
| Q3 25 | $51.1M | $67.5M | ||
| Q2 25 | $49.2M | $63.2M | ||
| Q1 25 | $46.8M | $52.6M | ||
| Q4 24 | $46.8M | $75.4M | ||
| Q3 24 | $44.2M | $57.9M | ||
| Q2 24 | $40.4M | $52.7M |
| Q1 26 | $13.7M | — | ||
| Q4 25 | $13.7M | $23.2M | ||
| Q3 25 | $13.7M | $5.1M | ||
| Q2 25 | $11.7M | $-553.0K | ||
| Q1 25 | $11.3M | $-11.2M | ||
| Q4 24 | $9.6M | $19.8M | ||
| Q3 24 | $9.1M | $-901.0K | ||
| Q2 24 | $8.0M | $-4.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% |
| Q1 26 | — | — | ||
| Q4 25 | 31.3% | 24.1% | ||
| Q3 25 | 33.2% | 5.1% | ||
| Q2 25 | 29.0% | -3.2% | ||
| Q1 25 | 29.0% | -24.3% | ||
| Q4 24 | 26.5% | 24.5% | ||
| Q3 24 | 24.3% | -4.3% | ||
| Q2 24 | 25.6% | -11.5% |
| Q1 26 | 25.4% | — | ||
| Q4 25 | 25.7% | 25.0% | ||
| Q3 25 | 26.8% | 7.5% | ||
| Q2 25 | 23.8% | -0.9% | ||
| Q1 25 | 24.0% | -21.4% | ||
| Q4 24 | 20.6% | 26.3% | ||
| Q3 24 | 20.7% | -1.6% | ||
| Q2 24 | 19.8% | -8.9% |
| Q1 26 | $0.81 | — | ||
| Q4 25 | $0.81 | $0.46 | ||
| Q3 25 | $0.81 | $0.10 | ||
| Q2 25 | $0.69 | $-0.01 | ||
| Q1 25 | $0.67 | $-0.23 | ||
| Q4 24 | $0.57 | $0.40 | ||
| Q3 24 | $0.54 | $-0.02 | ||
| Q2 24 | $0.48 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $346.1M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $562.2M | $354.6M |
| Total Assets | $5.9B | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $346.1M | — | ||
| Q4 25 | $464.4M | $137.5M | ||
| Q3 25 | $557.1M | $135.4M | ||
| Q2 25 | $365.1M | $116.9M | ||
| Q1 25 | $423.0M | $112.9M | ||
| Q4 24 | $387.6M | $116.2M | ||
| Q3 24 | $192.9M | $101.7M | ||
| Q2 24 | $342.8M | $102.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $1.3M | — | ||
| Q2 25 | $7.0M | — | ||
| Q1 25 | $7.6M | — | ||
| Q4 24 | $8.1M | — | ||
| Q3 24 | $9.0M | — | ||
| Q2 24 | $12.7M | — |
| Q1 26 | $562.2M | — | ||
| Q4 25 | $552.4M | $354.6M | ||
| Q3 25 | $538.4M | $321.9M | ||
| Q2 25 | $519.0M | $306.8M | ||
| Q1 25 | $505.8M | $295.5M | ||
| Q4 24 | $491.3M | $292.0M | ||
| Q3 24 | $489.0M | $257.5M | ||
| Q2 24 | $472.5M | $243.0M |
| Q1 26 | $5.9B | — | ||
| Q4 25 | $5.9B | $488.0M | ||
| Q3 25 | $5.8B | $453.3M | ||
| Q2 25 | $5.5B | $435.6M | ||
| Q1 25 | $5.4B | $424.6M | ||
| Q4 24 | $5.3B | $432.7M | ||
| Q3 24 | $4.9B | $390.4M | ||
| Q2 24 | $4.9B | $376.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.02× | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.03× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $15.0M |
| Free Cash FlowOCF − Capex | — | $12.8M |
| FCF MarginFCF / Revenue | — | 13.8% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $61.7M | $15.0M | ||
| Q3 25 | $16.9M | $22.1M | ||
| Q2 25 | $14.0M | $8.2M | ||
| Q1 25 | $14.3M | $6.6M | ||
| Q4 24 | $52.7M | $22.2M | ||
| Q3 24 | $12.4M | $10.2M | ||
| Q2 24 | $16.5M | $18.5M |
| Q1 26 | — | — | ||
| Q4 25 | $59.3M | $12.8M | ||
| Q3 25 | $16.6M | $19.5M | ||
| Q2 25 | $13.2M | $81.0K | ||
| Q1 25 | $13.4M | $-7.6M | ||
| Q4 24 | $46.3M | $8.5M | ||
| Q3 24 | $11.3M | $-9.2M | ||
| Q2 24 | $15.4M | $1.8M |
| Q1 26 | — | — | ||
| Q4 25 | 111.3% | 13.8% | ||
| Q3 25 | 32.4% | 28.8% | ||
| Q2 25 | 26.9% | 0.1% | ||
| Q1 25 | 28.5% | -14.5% | ||
| Q4 24 | 98.9% | 11.2% | ||
| Q3 24 | 25.7% | -15.9% | ||
| Q2 24 | 38.2% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 4.5% | 2.4% | ||
| Q3 25 | 0.6% | 3.9% | ||
| Q2 25 | 1.6% | 12.9% | ||
| Q1 25 | 2.0% | 27.0% | ||
| Q4 24 | 13.7% | 18.3% | ||
| Q3 24 | 2.4% | 33.5% | ||
| Q2 24 | 2.7% | 31.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.50× | 0.65× | ||
| Q3 25 | 1.23× | 4.35× | ||
| Q2 25 | 1.20× | — | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | 5.47× | 1.12× | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 2.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SMBK
| Net Interest Income | $45.9M | 85% |
| Noninterest Income | $7.9M | 15% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
